CNS 2a
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Wee1 Kinase Inhibitor AZD1775 and Combination Chemotherapy in Treating Children, Adolescents and Young Adults With Relapsed or Refractory Acute Myeloid Leukemia (NCT02791919) | National Cancer Institute (NCI) | 2017-05-25 |
Track CNS 2a automatically
Every clearance here is in the API, with alerts when new ones post.